tiprankstipranks
Valiant Organics Limited (IN:VALIANTORG)
:VALIANTORG
India Market
Want to see IN:VALIANTORG full AI Analyst Report?

Valiant Organics Limited (VALIANTORG) AI Stock Analysis

1 Followers

Top Page

IN:VALIANTORG

Valiant Organics Limited

(VALIANTORG)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 5.2)
Rating:60Neutral
Price Target:
₹316.00
▲(12.86% Upside)
Action:Reiterated
Date:05/20/26
The score is driven primarily by improving but still inconsistent fundamentals (recovering earnings and positive cash flow, but declining revenue and volatile margins/returns). Technicals are supportive with price above major moving averages and positive momentum indicators, while valuation appears reasonable at ~17x earnings but lacks dividend support due to missing yield data.
Positive Factors
Cash-generation recovery
Operating and free cash flow have returned to positive territory after prior losses, providing the company with improved internal funding for working capital, maintenance capex and selective reinvestment. This steadier cash profile supports durability through cycles and reduces near-term refinancing risk.
Negative Factors
Persistent revenue decline
Multi-year top-line decline suggests structural demand weakness, loss of volumes or pricing pressure in key product lines. Continued revenue shrinkage undermines scale, squeezes fixed-cost absorption and makes margin recovery and sustained returns harder without clear market-share or product-mix improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash-generation recovery
Operating and free cash flow have returned to positive territory after prior losses, providing the company with improved internal funding for working capital, maintenance capex and selective reinvestment. This steadier cash profile supports durability through cycles and reduces near-term refinancing risk.
Read all positive factors

Valiant Organics Limited (VALIANTORG) vs. iShares MSCI India ETF (INDA)

Valiant Organics Limited Business Overview & Revenue Model

Company Description
Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India. Its products include para chlorophenol; ortho chlorophenol; 2,4 di-chlorophenol; 2,4,6 tri- chlorophenol; 2,6 di-chlorophenol; and p...
How the Company Makes Money
Valiant Organics Limited primarily generates revenue by selling chemical products (including specialty chemical intermediates) to customers under supply contracts and purchase orders. Revenue is recognized from the sale of manufactured chemicals, ...

Valiant Organics Limited Financial Statement Overview

Summary
Financials show a partial recovery: profitability turned positive and operating profitability improved, leverage appears manageable, and operating/free cash flow are positive. Offsetting this, revenue has trended down for several years, margins and free cash flow have been volatile, and returns (ROE) are still far below 2021–2023 levels—raising questions about durability.
Income Statement
46
Neutral
Balance Sheet
64
Positive
Cash Flow
52
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue7.52B7.39B7.19B7.23B10.52B11.53B
Gross Profit2.67B2.13B2.62B470.01M1.81B2.17B
EBITDA895.07M881.77M615.51M425.75M1.77B2.12B
Net Income235.33M332.36M-37.36M-83.91M881.21M1.13B
Balance Sheet
Total Assets11.63B12.31B11.83B12.48B12.39B11.92B
Cash, Cash Equivalents and Short-Term Investments107.93M21.43M131.53M71.02M456.71M499.47M
Total Debt2.36B2.56B2.49B2.57B2.74B3.63B
Total Liabilities4.23B4.71B4.58B5.19B4.99B5.43B
Stockholders Equity7.40B7.59B7.25B7.29B6.89B6.13B
Cash Flow
Free Cash Flow797.52M439.27M256.03M90.70M862.19M-1.53B
Operating Cash Flow922.42M774.59M564.32M840.00M2.38B-307.47M
Investing Cash Flow-702.45M-898.89M-209.61M-649.88M-1.43B-1.24B
Financing Cash Flow-230.76M71.27M-318.13M-231.19M-1.12B1.67B

Valiant Organics Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price280.00
Price Trends
50DMA
256.01
Positive
100DMA
255.43
Positive
200DMA
287.84
Positive
Market Momentum
MACD
11.30
Negative
RSI
60.37
Neutral
STOCH
51.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Positive. The current price of 280 is below the 20-day moving average (MA) of 282.65, above the 50-day MA of 256.01, and below the 200-day MA of 287.84, indicating a bullish trend. The MACD of 11.30 indicates Negative momentum. The RSI at 60.37 is Neutral, neither overbought nor oversold. The STOCH value of 51.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VALIANTORG.

Valiant Organics Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
₹15.05B17.06-4.65%-0.30%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹8.46B17.042.78%
58
Neutral
₹5.76B-5.440.50%-9.39%-709.65%
52
Neutral
₹7.77B101.171.07%-14.55%-74.70%
49
Neutral
₹7.87B-10.640.39%
48
Neutral
₹8.48B-467.160.08%-14.36%1135.72%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:VALIANTORG
Valiant Organics Limited
301.05
-101.75
-25.26%
IN:BHARATWIRE
Bharat Wire Ropes Ltd.
218.25
32.15
17.28%
IN:DECCANCE
Deccan Cements Ltd
590.10
-191.82
-24.53%
IN:EVERESTIND
Everest Industries Limited
369.60
-131.04
-26.17%
IN:FAIRCHEMOR
Fairchem Organics Ltd
604.30
-213.00
-26.06%
IN:HERANBA
Heranba Industries Limited
194.20
-84.94
-30.43%

Valiant Organics Limited Corporate Events

Valiant Organics Files SEBI Compliance Certificate as All Shares Remain Dematerialized
Apr 4, 2026
Valiant Organics Limited has submitted to the stock exchanges a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and year ended 31 March 2026. The certificate, issued by it...
Valiant Organics Closes Trading Window Ahead of FY26 Results
Mar 26, 2026
Valiant Organics Limited has announced that its trading window for dealing in the company’s securities will be closed for directors, promoters, promoter group members, designated persons, their immediate relatives, and other connected person...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 20, 2026